Thermo Fisher Scientific (NYSE:TMO – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” ...
Bernstein upgraded Thermo Fisher (TMO) to Outperform from Market Perform with a $630 price target While the setup in 2025 for U.S. Life ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma ...
International Assets Investment Management LLC trimmed its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) ...
Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.
Enter Thermo Fisher Scientific, a life-science company with the capabilities ... in antisense and RNA-interference technologies and as aptamers). Thermo Fisher Scientific has over 40 years of ...
Thermo Fisher Scientific TMO has outperformed the market over the past 20 years by 7.25% on an annualized basis producing an ...
Thermo Fisher (TMO) announced the UK Biobank Pharma Proteomics Project, or UKB-PPP, has selected its Olink Explore Platform to support the ...
Thermo Fisher Scientific. “This new era of non-viral delivery technologies helps inspire innovation in life science research and can pave the way for groundbreaking genetic medicines.” Invitrogen ...
In drug delivery, nanoscale technologies enhance how medications work by improving ... Number of Hedge Fund Holders: 98 ...
(V), Linde plc (LIN) and Thermo Fisher Scientific Inc. (TMO), as well as two micro-cap stocks Tile Shop Holdings, Inc. (TTSH) and Autoscope Technologies Corporation (AATC). Investors are also ...
--(BUSINESS WIRE)--Thermo ... technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen ...